Doxorubicin Plus Dual Checkpoint Blockade for Soft Tissue Sarcomas
Clinical trial NCT04028063 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04028063
- Sponsor
- University of Colorado, Denver
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-28
- Primary completion
- 2027-04-07
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.